19-46756378-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024301.5(FKRP):c.928G>T(p.Glu310Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,411,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E310E) has been classified as Likely benign.
Frequency
Consequence
NM_024301.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FKRP | NM_024301.5 | c.928G>T | p.Glu310Ter | stop_gained | 4/4 | ENST00000318584.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FKRP | ENST00000318584.10 | c.928G>T | p.Glu310Ter | stop_gained | 4/4 | 1 | NM_024301.5 | P1 | |
FKRP | ENST00000391909.7 | c.928G>T | p.Glu310Ter | stop_gained | 4/4 | 2 | P1 | ||
FKRP | ENST00000597339.5 | n.247-5455G>T | intron_variant, non_coding_transcript_variant | 5 | |||||
FKRP | ENST00000600646.5 | n.247+7713G>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000251 AC: 4AN: 159598Hom.: 0 AF XY: 0.0000343 AC XY: 3AN XY: 87410
GnomAD4 exome AF: 0.0000106 AC: 15AN: 1411748Hom.: 0 Cov.: 32 AF XY: 0.0000115 AC XY: 8AN XY: 697914
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2021 | Observed with a pathogenic variant in published literature but it unknown if these variants occurred in cis or in trans (Poppe et al., 2003); Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 186 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 15580560, 19900540, 23591631, 12707425) - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 31, 2019 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;C4284790:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 12, 2021 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2I Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 13, 2017 | - - |
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 31, 2023 | Variant summary: FKRP c.928G>T (p.Glu310X) results in a premature termination codon and is predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. Although the variant is not expected to cause absense of the protein through nonsense mediated decay, the variant disrupts the last 186 amino acids in the protein sequence. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.948del [p.Cys317fs], c.1027G>T [p.Glu343Ter]). The variant allele was found at a frequency of 2.5e-05 in 159598 control chromosomes (gnomAD). c.928G>T has been reported in the literature as a biallelic genotype in individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (e.g. Poppe_2003, Frosk_2005, Sframeli_2017). These data indicate that the variant may be associated with disease. Experimental evidence confirms the variant results in loss-of-function: homozygous knock-in of the variant human gene in a mouse model of disease was embryonically lethal (Blaeser_2013), despite evidence that the variant does not impact protein production or secretion (Lu_2010). Six ClinVar submitters have assessed the variant since 2014: one classified the variant as likely pathogenic, and five as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 15, 2023 | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2022 | The p.E310* variant (also known as c.928G>T), located in coding exon 1 of the FKRP gene, results from a G to T substitution at nucleotide position 928. This changes the amino acid from a glutamic acid to a stop codon within coding exon 1. This alteration occurs at the 3' terminus of theFKRP gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 186 (38%) amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This variant has been reported in compound heterozygotes from limb-girdle muscular dystrophy cohorts (Poppe M et al. Neurology, 2003 Apr;60:1246-51; Frosk P et al. Hum Mutat, 2005 Jan;25:38-44; Murphy LB et al. Ann Clin Transl Neurol, 2020 05;7:757-766). Other truncating alterations downstream have been observed in individuals with a personal and/or family history that is consistent with FKRP-related disease (Mercuri E et al. Arch. Neurol., 2006 Feb;63:251-7; Sveen ML et al. Ann Neurol, 2006 May;59:808-15). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Walker-Warburg congenital muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 27, 2023 | This sequence change creates a premature translational stop signal (p.Glu310*) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 186 amino acid(s) of the FKRP protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with limb-girdle muscular dystrophy (PMID: 12707425, 15580560). ClinVar contains an entry for this variant (Variation ID: 550361). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects FKRP function (PMID: 23591631). This variant disrupts a region of the FKRP protein in which other variant(s) (p.Trp432*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at